Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predicting stroke in heart failure and reduced ejection fraction without atrial fibrillation
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-08-26
DOI
10.1093/eurheartj/ehac487
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factor IX(a) inhibitors: an updated patent review (2003-present)
- (2022) Daniel K. Afosah et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
- (2022) Angelica Rivas et al. THROMBOSIS AND HAEMOSTASIS
- Natriuretic Peptide Plasma Concentrations and Risk of Cardiovascular Versus Non-Cardiovascular Events in Heart Failure with Reduced Ejection Fraction Insights from the PARADIGM-HF and ATMOSPHERE Trials
- (2021) Muhammad Shahzeb Khan et al. AMERICAN HEART JOURNAL
- Ischemic Stroke and Heart Failure: Facts and Numbers. An Update
- (2021) Anush Barkhudaryan et al. Journal of Clinical Medicine
- Factor XI as a Target for New Anticoagulants
- (2021) James C. Fredenburgh et al. Hamostaseologie
- The CHA2DS2-VASc Score for Risk Stratification of Stroke in Heart Failure With-vs-Without Atrial Fibrillation
- (2021) George R. Marzouka et al. AMERICAN JOURNAL OF CARDIOLOGY
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to N-Terminal Pro-B-Type Natriuretic Peptide: Insights From the DAPA-HF Trial
- (2021) Jawad H. Butt et al. Circulation-Heart Failure
- Pharmacokinetics and pharmacodynamics of Abelacimab (MAA868), a novel dual inhibitor of Factor XI and Factor XIa
- (2021) B. Alexander Yi et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Milvexian for the Prevention of Venous Thromboembolism
- (2021) Jeffrey I. Weitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD
- (2021) Michael Walsh et al. Kidney International Reports
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
- (2019) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial
- (2019) Mandeep R Mehra et al. EUROPEAN HEART JOURNAL
- Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?
- (2019) Aldo P Maggioni et al. EUROPEAN HEART JOURNAL
- Predicting stroke and death in patients with heart failure using CHA2DS2-VASc score in Asia
- (2019) Mi Kyoung Son et al. BMC Cardiovascular Disorders
- CHA2DS2-VASc score performance to predict stroke after acute decompensated heart failure with and without reduced ejection fraction
- (2019) Anat Berkovitch et al. EUROPACE
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure as a Risk Factor for Stroke
- (2018) Woohyeun Kim et al. Journal of Stroke
- Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation
- (2018) Christian Madelaire et al. JACC-Heart Failure
- Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
- (2018) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
- (2016) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials
- (2015) A. H. Abdul-Rahim et al. CIRCULATION
- Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation
- (2015) Line Melgaard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis
- (2015) Harry R. Büller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stroke in Heart Failure in Sinus Rhythm: The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial
- (2013) Patrick M. Pullicino et al. CEREBROVASCULAR DISEASES
- Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact
- (2013) John J. V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
- (2012) Shunichi Homma et al. NEW ENGLAND JOURNAL OF MEDICINE
- On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data
- (2011) Hajime Uno et al. STATISTICS IN MEDICINE
- Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOS
- (2010) Henry Krum et al. EUROPEAN JOURNAL OF HEART FAILURE
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Prognostic Models With Competing Risks
- (2009) Marcel Wolbers et al. EPIDEMIOLOGY
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now